Evidence map›Paper›PMID 36409717›Full record

ArticlePloS one2022

A comparative study on renewable and traditional electricity: The influence of the European Union framework and the impact of COVID-19.

Florin Teodor Boldeanu, José Antonio Clemente-Almendros, Luis Alberto Seguí-Amortegui, Constantin Duguleana

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Florin Teodor BoldeanuFaculty of Economic Sciences and Business Administration, Department of Finance, Accounting and Economic Theory, Transilvania University of Brasov, Brașov, Romania.ORCID 0000-0002-6741-9688
José Antonio Clemente-AlmendrosBusiness and Communication Faculty, International University of La Rioja, Logroño, Spain.ORCID 0000-0002-8934-471X
Luis Alberto Seguí-AmorteguiBusiness and Communication Faculty, International University of La Rioja, Logroño, Spain.
Constantin DuguleanaFaculty of Economic Sciences and Business Administration, Department of Finance, Accounting and Economic Theory, Transilvania University of Brasov, Brașov, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By means of the event study approach, we analyse the effect of COVID-19 on listed European renewable and traditional electricity companies, inside and outside the European Union, for the pandemic announcement and lockdowns. We find that the pandemic negatively affected both subsectors of electricity production, but the negative effect was more intense for renewable electricity companies, since they represent a riskier investment. Moreover, this negative effect was larger for European electricity companies than for companies from countries that do not belong to the European Union. Our results show the riskier profile of the clean energy industry together with the importance of a stable and supportive regulatory framework to develop and consolidate renewable energy. Our findings have important implications for policymakers. In addition to the intrinsic risks associated with renewable energy, this type of investment poses policy and regulatory risks, which they should take into account when evaluating future energy policies. Policymakers must be aware of the importance of these specific risks, and seek to respond to investors' expectations about long-term, stable regulations.

Indexed as

COVID-19Communicable Disease ControlElectricityEuropean UnionHumansRenewable Energy

Identifiers

PMID36409717
PMCPMC9678253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.